Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research

May 30, 2024

https://www.globenewswire.com/news-release/2024/05/30/2890606/0/en/Fortrea-Introduces-Comprehensive-Solution-to-Improve-Diversity-and-Inclusion-in-Clinical-Research.html

DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq:FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity and inclusion (D&I) of participants in clinical trials. Fortrea’s D&I solution is designed to expand patient access to participate in clinical trials and address the U.S. Food and Drug Administration (FDA) requirements, under The Food and Drug Omnibus Reform Act, to increase enrollment of underrepresented populations in clinical trials.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.